Origin & Mission

Constance LifeSciences is a vertically integrated medicinal cannabis company that is setting the industry standard for quality, potency and consistency with a new category of whole-plant cannabis extracts. We are ushering in a new era of care in which whole-plant cannabis extracts are integrated into traditional healthcare to provide physicians and their patients with expanded treatment options, filling the gap between traditional pharmaceuticals and commonplace cannabis products. Our mission is to act as an herbal compounding apothecary providing physicians access to the highest quality and greatest variety of cannabis extracts – and allowing for individual, customized patient protocols.

After suffering for more than a decade from a misdiagnosed autoimmune disease and nearly dying from the medication prescribed to help alleviate pain and inflammation that ravaged her body, Finley turned to medicinal cannabis for relief. When both her condition and her pain dramatically improved, she began her journey to develop the standardized, whole-plant cannabis extracts her company is known for today.

Finley is driven by the science behind the medicinal benefits of cannabis.

She is now recognized and respected as an expert throughout the industry in standardization and on the synergistic relationship between the compounds found within the cannabis plant – often referred to as the “Entourage Effect.” Modern clinical herbalist principles and scientific research indicate that cannabinoids, like THC and CBD, found in cannabis are more effective when working in tandem with the entire phytochemical profile of the female cannabis flower versus working in isolation. Armed with this deep knowledge, Finley developed a sciencebased, tightly-controlled and quantitatively-defined extraction method using organic, pharmaceutical-grade ethanol that is both safe for those with compromised immune systems and best preserves all the naturally occurring cannabinoids, terpenes and flavonoids in the cannabis flower.

DISCLAIMER: These statements have not been evaluated by the United States Food and Drug Administration. The U.S. federal government (including the FDA) maintains that cannabis is a Schedule 1 drug under the federal Controlled Substances Act, with no accepted medical use, despite the mounting evidence from the international medical community. As a result, our products cannot go through FDA testing that would enable us to make health claims, and we are required to state that Constance LifeSciences Corp. & Constance Pure Botanical Extracts products are not intended to diagnose, treat, cure, or prevent any disease, illness or medical condition. Constance LifeSciences Corp. & Constance Pure Botanical Extracts makes no healing, curative or medical claims or warranties regarding its products. If you have a medical condition or illness, please consult your physician.